Charles Schwab’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,400
Closed -$9.39K 3497
2025
Q4
$9.39K Hold
34,400
﹤0.01% 3455
2025
Q3
$15.6K Hold
34,400
﹤0.01% 3455
2025
Q2
$21.9K Hold
34,400
﹤0.01% 3488
2025
Q1
$32.1K Hold
34,400
﹤0.01% 3435
2024
Q4
$33K Hold
34,400
﹤0.01% 3465
2024
Q3
$31.3K Hold
34,400
﹤0.01% 3462
2024
Q2
$23.5K Hold
34,400
﹤0.01% 3577
2024
Q1
$21.4K Hold
34,400
﹤0.01% 3434
2023
Q4
$23.7K Hold
34,400
﹤0.01% 3471
2023
Q3
$31.6K Hold
34,400
﹤0.01% 3459
2023
Q2
$29.9K Buy
+34,400
New +$31K ﹤0.01% 3508
2022
Q1
Sell
-24,916
Closed -$52K 3608
2021
Q4
$52K Hold
24,916
﹤0.01% 3512
2021
Q3
$47K Buy
+24,916
New +$46.1K ﹤0.01% 3459
2021
Q2
Sell
-123,319
Closed -$441K 3492
2021
Q1
$441K Hold
123,319
﹤0.01% 3121
2020
Q4
$262K Buy
123,319
+13,158
+12% +$23.2K ﹤0.01% 3209
2020
Q3
$154K Buy
110,161
+12,988
+13% +$22.6K ﹤0.01% 3215
2020
Q2
$190K Buy
+97,173
New +$178K ﹤0.01% 3177

Other funds holding MLSS

Charles Schwab's MLSS Position: Q1 2026 in Review

Charles Schwab sold out of Milestone Scientific (MLSS) in Q1 2026, closing a stake of 34,400 shares — an estimated $9.39K sold.

Charles Schwab first reported a position in MLSS in Q2 2020 and held it in 17 quarters. The position peaked at $441K in Q1 2021. 32 funds tracked by Wall St. Rank hold MLSS as of Q1 2026.

  • Charles Schwab reported no remaining Milestone Scientific position as of Q1 2026 after selling out during the quarter.
  • Charles Schwab sold 34,400 Milestone Scientific shares in Q1 2026, an estimated $9.39K.
  • Charles Schwab first reported a position in Milestone Scientific in Q2 2020 and held it in 17 quarters.
  • Charles Schwab's Milestone Scientific position peaked at $441K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Milestone Scientific as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.